Substances on the Monitoring Program are reviewed annually and may later be added to the Prohibited List
More serious but rare adverse events include pancreatitis (0.2% incidence), gallbladder disease requiring surgical intervention, and medullary thyroid carcinoma risk in genetically predisposed individuals (contraindicated in patients with personal or family history of MTC or MEN2 syndrome)
PlexusDx's gradual dosing approach and nutritional support minimize this risk
Compared to controls, a progressive increase in the risk of metabolic syndrome was found among subjects with normal GGT [odds ratio (OR) = 1.71], isolated elevation of GGT (OR = 3.06), isolated elevation of ALT (OR = 4.00), and elevation of both GGT and ALT activities [45]
The final model of GLP-1RPF-06372222Fab7F38 contained 29257, 315474 of GLP-1R, 258314 residues of rubredoxin, and chain B and chain C of Fab7F38